SubjectWell Raises $10M to Expand Its Risk-Free Patient Recruitment Marketplace

AUSTIN, Texas--()--SubjectWell, the risk-free clinical trials marketplace for patient recruitment, announced today its $10 million in Series A funding led by Windham Venture Partners, with participation from previous investors Healthy Ventures and Geekdom Fund. This funding bolsters SubjectWell’s mission of building awareness of and increasing participation in clinical research by providing a single marketplace that allows prospective patients to match to any available clinical trials.

 

“The largest barrier to participation in clinical trials is awareness — patients aren’t aware clinical trials exist and don’t know how to get started,” said Ivor Clarke, CEO at SubjectWell. “By building awareness and creating the first true trial marketplace, we provide patients with greater choice and access to innovative treatments. Our investors’ support allows us to reach more interested patients and fill our clients’ studies faster.”

This round of funding will support SubjectWell’s international expansion by helping the company extend its services beyond North America and into Europe, South America, and the United Kingdom.

“Our growth is not just deepening the patient pool,” said Tony Averbeck, vice president of business development at SubjectWell. “Our performance-based pricing model, where we’re only compensated for patients who randomize, is specifically designed to allow every sponsor to bring all of their trials into SubjectWell’s marketplace.”

“Despite all the recent advances in medicine, clinical trials continue to be a major pain point for stakeholders. The vast majority of trials are delayed and many ultimately fail due to poor patient selection,” said Adam Fine, general partner and CEO at Windham. “We have looked deeply at the clinical trial space and concluded that SubjectWell, with hundreds of studies already recruiting through its marketplace, has demonstrated the most effective model for enrolling clinical trials. We are excited to partner with this terrific team.”


About Windham
Windham Venture Partners is a NY-based venture capital firm focused on healthcare, with particular interest in medtech and healthcare IT.

Windham partners with exceptional entrepreneurs and companies that are developing game-changing technologies to serve unmet needs, improve outcomes and help the lives of large numbers of patients. Windham is led by seasoned healthcare industry executives, operators and investors.

Contacts

Jane Byram
SCORR Marketing
512.626.2758
jane@scorrmarketing.com

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

SubjectWell

SubjectWell, the risk-free clinical trials marketplace for patient recruitment, is raising awareness of clinical research in the general population and providing patients more choice and easy access to innovative treatment options.